---
title: "ALLERGY THERAPEUTICS PLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/88e63737-eab5-59cd-8867-7395d040ea2e
json: https://whiteintel.dev/api/public/dossier/88e63737-eab5-59cd-8867-7395d040ea2e
identifier: oo:GB-COH-05141592
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ALLERGY THERAPEUTICS PLC

**Type:** Company  
**Identifier:** `oo:GB-COH-05141592`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/88e63737-eab5-59cd-8867-7395d040ea2e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/88e63737-eab5-59cd-8867-7395d040ea2e  

## Cross-source identity

The same real-world entity, resolved across sources:

- **Allergy Therapeutics Plc** — source · `gb-coh:5141592` — https://whiteintel.dev/entity/298b7c47-949b-416d-96bd-cb2874c1065e
- **ALLERGY THERAPEUTICS PLC** — GLEIF · `lei:213800PQ7AHK7KGVOE23` — https://whiteintel.dev/entity/60c47c20-c987-5101-beec-6bbad6415282

## Ownership & control

### Owners / controllers

- **SKYGEM ACQUISITION LIMITED** (beneficial owner) — 75% — https://whiteintel.dev/entity/88913131-d415-50fe-a4fb-153b31468cb5
- **SKYGEM ACQUISITION LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/88913131-d415-50fe-a4fb-153b31468cb5
- **Abbott Laboratories** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/65dc6b99-3bf1-464d-af81-52b19d00a5d5
- **Chemoform Ag** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/ec7014df-a94b-4c2b-a7f3-9274269bd0f8
- **Chemoform Ag** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/ec7014df-a94b-4c2b-a7f3-9274269bd0f8

### Holdings / subsidiaries

- **ALLERGY THERAPEUTICS (HOLDINGS) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/080daa94-4458-55e6-acf5-2bf41eded592

### UBO chain (walk to the ultimate owner)

1. **SKYGEM ACQUISITION LIMITED** — beneficial owner 75% → *ALLERGY THERAPEUTICS PLC*
1. **SKYGEM ACQUISITION LIMITED** — beneficial owner 62.5% → *ALLERGY THERAPEUTICS PLC*
1. **Abbott Laboratories** — beneficial owner 37.5% → *ALLERGY THERAPEUTICS PLC*
1. **Chemoform Ag** — beneficial owner 37.5% → *ALLERGY THERAPEUTICS PLC*
1. **Chemoform Ag** — beneficial owner 62.5% → *ALLERGY THERAPEUTICS PLC*
2. **Mr Zheqing Shen** — beneficial owner 100% → *SKYGEM ACQUISITION LIMITED*
2. **Mr Zheqing Shen** — beneficial owner → *SKYGEM ACQUISITION LIMITED*

## Company profile (live · UK Companies House)

- **Company number:** `05141592`
- **Status:** Active
- **Type:** Public Limited Company
- **Incorporated:** 2004-06-01
- **Registered office:** DOMINION WAY, WORTHING, WEST SUSSEX, BN14 8SA
- **SIC:** 21200 - Manufacture of pharmaceutical preparations

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/05141592
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/05141592

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ALLERGY THERAPEUTICS PLC**. Human view: https://whiteintel.dev/entity/88e63737-eab5-59cd-8867-7395d040ea2e · Structured JSON: https://whiteintel.dev/api/public/dossier/88e63737-eab5-59cd-8867-7395d040ea2e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._